InvestorsHub Logo
Followers 24
Posts 1944
Boards Moderated 0
Alias Born 07/07/2014

Re: djmurdock post# 526

Wednesday, 03/22/2017 9:54:01 PM

Wednesday, March 22, 2017 9:54:01 PM

Post# of 2676
Zynerba's transdermal approach has significant benefits

*Patent protection
*synthetic manufacturing process can be scaled for large volume markets
*Attractive COGS and no royalty obligations should result in high gross margins


Been loading on these dips!!!